Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study.

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study.
Related ArticlesTumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study. Neurology. 2021 Feb 19;: Authors: Kang X, Ploner A, Pedersen NL, Bandres-Ciga S, Noyce AJ, Wirdefeldt K, Williams DM Abstract OBJECTIVE: To evaluate the effects of long-term tumor necrosis factor (TNF) inhibition on the risk and age at onset of Parkinson disease (PD), we performed a two-sample Mendelian ... read more
Source: PubMedPublished on 2021-02-21